One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia
- 1 January 2006
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 81 (1), 1-15
- https://doi.org/10.1016/j.schres.2005.07.038
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal studySchizophrenia Research, 2001
- Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical CorrelatesAmerican Journal of Psychiatry, 2000
- Quality of life and new antipsychotics in schizophrenia. Are patients better off?International Journal of Social Psychiatry, 1999
- The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performanceBiological Psychiatry, 1994
- Comparison of risperidone and clozapine on clinical and cognitive functions in psychotic disordersBiological Psychiatry, 1994
- Impaired Attention, Genetics, and the Pathophysiology of SchizophreniaSchizophrenia Bulletin, 1994
- The Generalized Pattern of Neuropsychological Deficits in Outpatients With Chronic Schizophrenia With Heterogeneous Wisconsin Card Sorting Test ResultsArchives of General Psychiatry, 1991
- Demonstration of savings on the AVLT and development of a parallel formJournal of Clinical and Experimental Neuropsychology, 1989
- Attentional measures in a study of children at high-risk for schizophreniaJournal of Psychiatric Research, 1978